FRA:IX1 • US45168D1046
ChartMill assigns a Buy % Consensus number of 81% to IX1.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-13 | Credit Suisse | Maintains | Outperform |
| 2021-08-03 | Goldman Sachs | Maintains | Neutral |
| 2021-08-02 | Barclays | Maintains | Overweight |
| 2021-07-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-02-17 | Barclays | Initiate | Overweight |
22 analysts have analysed IX1.DE and the average price target is 692.16 EUR. This implies a price increase of 28.23% is expected in the next year compared to the current price of 539.8.
The consensus rating for IDEXX LABORATORIES INC (IX1.DE) is 80.9091 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering IDEXX LABORATORIES INC (IX1.DE) is 22.